(Q57396239)
Statements
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT) (English)
0 references
October 2011
0 references
162
0 references
4
0 references
748-755.e3
0 references